Sign up
Quantellect · Congress · Trade Detail
NASDAQ: REGNRegeneron Pharmaceuticals Inc
DemocratHouse

Thomas R. Suozzi sold Regeneron Pharmaceuticals Inc (NASDAQ: REGN)

Thomas R. Suozzi (D-NY), a U.S. Representative, has disclosed 5 trades in Regeneron Pharmaceuticals Inc (REGN) since 2018, 2 purchases and 3 sales, worth an estimated $223K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Thomas R. Suozzi sold $15,001 - $50,000 of Regeneron Pharmaceuticals Inc (NASDAQ: REGN) on November 7, 2018. Since that trade, REGN is up +92.50% against the S&P 500 up +191.13%, an outperformance of -98.63%.

Across these filings, Thomas R. Suozzi has been a net seller of REGN (a buy-to-sell ratio of 0.67). The most recent disclosed REGN transaction shown was dated September 16, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

REGN trades
5
Disclosed Vol
$223K
Buys
2
40%
Sells
3
60%
Buy / Sell
0.67
ratio
First → Last
2018–2019

Thomas R. Suozzi's REGN trades vs the price

REGN is up +92.50% since Thomas R. Suozzi sold on November 7, 2018, versus +191.13% for the S&P 500.

Performance since this trade

Price change since trade
+92.50%
S&P 500 change since trade
+191.13%
Outperformance vs S&P 500
-98.63%

All Thomas R. Suozzi REGN trades

TradedTypeSizeReturnEst. profit
September 16, 2019SELL$283.55+145.26%
August 21, 2019SELL$295.34+135.46%
May 2, 2019BUY$332.66+109.05%+$81K
November 7, 2018SELL$361.27+92.50%
November 5, 2018BUY$352.02+97.55%+$31K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Thomas R. Suozzi & REGN trading FAQ

Is it legal for Thomas R. Suozzi to trade Regeneron Pharmaceuticals Inc (REGN) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Regeneron Pharmaceuticals Inc (REGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Thomas R. Suozzi sell REGN?

Thomas R. Suozzi disclosed a sale of $15,001 - $50,000 of Regeneron Pharmaceuticals Inc (REGN) on November 7, 2018, according to public STOCK Act filings.

How has REGN performed since Thomas R. Suozzi's trade?

Since Thomas R. Suozzi sold REGN on November 7, 2018, the stock is up +92.50%, versus +191.13% for the S&P 500 over the same period, an outperformance of -98.63%.

How many times has Thomas R. Suozzi traded REGN?

Thomas R. Suozzi has disclosed 5 REGN trades since 2018 (2 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional REGN trades?

Quantellect tracks every disclosed congressional trade in Regeneron Pharmaceuticals Inc (REGN) on the Regeneron Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.

Thomas R. Suozzi's REGN tradesAll congressional filings for Regeneron Pharmaceuticals IncThomas R. Suozzi's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.